FI870501A0 - Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut - Google Patents
Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolutInfo
- Publication number
- FI870501A0 FI870501A0 FI870501A FI870501A FI870501A0 FI 870501 A0 FI870501 A0 FI 870501A0 FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 870501 A0 FI870501 A0 FI 870501A0
- Authority
- FI
- Finland
- Prior art keywords
- melanoma
- producing
- antigenic
- host cells
- associated antigen
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title 2
- 101000798109 Homo sapiens Melanotransferrin Proteins 0.000 title 1
- 102100032239 Melanotransferrin Human genes 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82731386A | 1986-02-07 | 1986-02-07 | |
| US82731386 | 1986-02-07 | ||
| US07/007,230 US5262177A (en) | 1986-02-07 | 1987-01-27 | Recombinant viruses encoding the human melanoma-associated antigen |
| US723087 | 1987-01-27 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI870501A0 true FI870501A0 (fi) | 1987-02-06 |
| FI870501A FI870501A (fi) | 1987-08-08 |
| FI94836B FI94836B (fi) | 1995-07-31 |
| FI94836C FI94836C (fi) | 1995-11-10 |
Family
ID=26676698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI870501A FI94836C (fi) | 1986-02-07 | 1987-02-06 | Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut |
Country Status (18)
| Country | Link |
|---|---|
| JP (3) | JP2664673B2 (fi) |
| BE (1) | BE1000175A3 (fi) |
| CH (1) | CH675424A5 (fi) |
| DE (1) | DE3703702C2 (fi) |
| DK (1) | DK63287A (fi) |
| ES (2) | ES2012815A6 (fi) |
| FI (1) | FI94836C (fi) |
| GR (1) | GR870195B (fi) |
| HU (1) | HU209144B (fi) |
| IE (1) | IE59597B1 (fi) |
| IT (1) | IT1222359B (fi) |
| MX (1) | MX9203574A (fi) |
| NL (1) | NL8700285A (fi) |
| NO (1) | NO178931C (fi) |
| NZ (1) | NZ219192A (fi) |
| OA (1) | OA08478A (fi) |
| PT (1) | PT84255B (fi) |
| SE (2) | SE506024C2 (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19821925A1 (de) * | 1998-05-15 | 1999-11-18 | Roehnisch Tim | Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien |
| JP4414023B2 (ja) * | 1999-08-05 | 2010-02-10 | オリエンタル酵母工業株式会社 | 関節炎関連メラノトランスフェリンの測定方法および試薬 |
| JP4708027B2 (ja) * | 2002-10-01 | 2011-06-22 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法 |
| US8207314B2 (en) * | 2003-05-16 | 2012-06-26 | Sanofi Pasteur Limited | Tumor antigens for prevention and/or treatment of cancer |
-
1987
- 1987-02-05 NZ NZ219192A patent/NZ219192A/xx unknown
- 1987-02-06 NL NL8700285A patent/NL8700285A/nl not_active Application Discontinuation
- 1987-02-06 IE IE31987A patent/IE59597B1/en not_active IP Right Cessation
- 1987-02-06 OA OA59065A patent/OA08478A/xx unknown
- 1987-02-06 ES ES8700288A patent/ES2012815A6/es not_active Expired - Fee Related
- 1987-02-06 HU HU87472A patent/HU209144B/hu not_active IP Right Cessation
- 1987-02-06 IT IT19291/87A patent/IT1222359B/it active
- 1987-02-06 FI FI870501A patent/FI94836C/fi not_active IP Right Cessation
- 1987-02-06 GR GR870195A patent/GR870195B/el unknown
- 1987-02-06 JP JP62026191A patent/JP2664673B2/ja not_active Expired - Lifetime
- 1987-02-06 PT PT84255A patent/PT84255B/pt not_active IP Right Cessation
- 1987-02-06 NO NO870475A patent/NO178931C/no unknown
- 1987-02-06 SE SE8700466A patent/SE506024C2/sv not_active IP Right Cessation
- 1987-02-06 DE DE3703702A patent/DE3703702C2/de not_active Expired - Fee Related
- 1987-02-06 BE BE8700094A patent/BE1000175A3/fr not_active IP Right Cessation
- 1987-02-06 DK DK063287A patent/DK63287A/da not_active Application Discontinuation
- 1987-02-09 CH CH471/87A patent/CH675424A5/de not_active IP Right Cessation
-
1989
- 1989-06-15 ES ES8902106A patent/ES2017258A6/es not_active Expired - Fee Related
-
1992
- 1992-06-26 MX MX9203574A patent/MX9203574A/es not_active Application Discontinuation
- 1992-10-07 SE SE9202934A patent/SE9202934D0/xx unknown
-
1996
- 1996-03-12 JP JP8054929A patent/JPH08280390A/ja active Pending
- 1996-03-12 JP JP8054928A patent/JPH09135692A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SE506024C2 (sv) | 1997-11-03 |
| BE1000175A3 (fr) | 1988-07-12 |
| NO178931C (no) | 1996-07-03 |
| HUT43107A (en) | 1987-09-28 |
| NZ219192A (en) | 1991-10-25 |
| FI870501A (fi) | 1987-08-08 |
| JPH09135692A (ja) | 1997-05-27 |
| SE8700466L (sv) | 1987-08-08 |
| ES2017258A6 (es) | 1991-01-16 |
| HU209144B (en) | 1994-03-28 |
| MX9203574A (es) | 1992-07-01 |
| IE870319L (en) | 1987-08-07 |
| FI94836C (fi) | 1995-11-10 |
| IT8719291A0 (it) | 1987-02-06 |
| IE59597B1 (en) | 1994-03-09 |
| GR870195B (en) | 1987-06-10 |
| DK63287A (da) | 1987-08-08 |
| JP2664673B2 (ja) | 1997-10-15 |
| JPH08280390A (ja) | 1996-10-29 |
| PT84255B (pt) | 1989-11-30 |
| IT1222359B (it) | 1990-09-05 |
| DK63287D0 (da) | 1987-02-06 |
| NL8700285A (nl) | 1987-09-01 |
| NO870475D0 (no) | 1987-02-06 |
| OA08478A (fr) | 1988-07-29 |
| FI94836B (fi) | 1995-07-31 |
| NO178931B (no) | 1996-03-25 |
| NO870475L (no) | 1987-08-10 |
| ES2012815A6 (es) | 1990-04-16 |
| JPS62294698A (ja) | 1987-12-22 |
| DE3703702A1 (de) | 1988-02-18 |
| SE8700466D0 (sv) | 1987-02-06 |
| DE3703702C2 (de) | 1997-07-10 |
| PT84255A (en) | 1987-03-01 |
| SE9202934D0 (sv) | 1992-10-07 |
| CH675424A5 (en) | 1990-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3583293D1 (de) | Lymphadenopathie-assoziierte huellenantigene und deren verwendungen. | |
| FI870447A0 (fi) | Htlv-iii-hoeljepeptider. | |
| DE3888086D1 (de) | Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine. | |
| DK0757717T3 (da) | Papillomavirusvacciner | |
| ES2002490A6 (es) | Un metodo de preparar un virus recombinante | |
| ATE97164T1 (de) | Rekombinantes vaccinia-virus mva. | |
| NO912825L (no) | Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper. | |
| AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
| FI864991A (fi) | Expression och diagnostisk anvaendning av peptider kodade av gag-region vilka peptider aer immunologiskt reaktiva med antikroppar av lav-virus. | |
| DK457687A (da) | Antigenisk aktive proteiner og peptider, og vacciner mod virus for felin peritonitis (fipv) med indhold af saadanne proteiner eller peptider | |
| FI870501A0 (fi) | Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| DK498387D0 (da) | Virus-dna-sekvens | |
| OA09653A (en) | Rubella peptides | |
| CA2088478A1 (en) | Cloning and expression of a rhoptry associated protein of p. falciparum | |
| FI90562C (fi) | Uudet Bacillus thuringiensis serovar. israelensis-mutantit, menetelmä itiöttömien, väkevöityjen, sääskille toksisten proteiinipreparaattien valmistamiseksi ja niiden käyttö | |
| ATE69056T1 (de) | Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper. | |
| ES8801959A1 (es) | Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: ONCOGEN |